NO318600B1 - Anvendelse av en karboanhydraseinhibitor for okning av blodstromshastigheten i retina og optisk nervehode for a bevare synet - Google Patents

Anvendelse av en karboanhydraseinhibitor for okning av blodstromshastigheten i retina og optisk nervehode for a bevare synet Download PDF

Info

Publication number
NO318600B1
NO318600B1 NO19975330A NO975330A NO318600B1 NO 318600 B1 NO318600 B1 NO 318600B1 NO 19975330 A NO19975330 A NO 19975330A NO 975330 A NO975330 A NO 975330A NO 318600 B1 NO318600 B1 NO 318600B1
Authority
NO
Norway
Prior art keywords
carbonic anhydrase
approx
anhydrase inhibitor
retina
blood flow
Prior art date
Application number
NO19975330A
Other languages
English (en)
Norwegian (no)
Other versions
NO975330L (no
NO975330D0 (no
Inventor
William Eric Sponsen
Alon Harris
Original Assignee
Advanced Res & Tech Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Res & Tech Inst filed Critical Advanced Res & Tech Inst
Publication of NO975330D0 publication Critical patent/NO975330D0/no
Publication of NO975330L publication Critical patent/NO975330L/no
Publication of NO318600B1 publication Critical patent/NO318600B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19975330A 1995-05-22 1997-11-20 Anvendelse av en karboanhydraseinhibitor for okning av blodstromshastigheten i retina og optisk nervehode for a bevare synet NO318600B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/445,839 US5789435A (en) 1995-05-22 1995-05-22 Method to increase retinal and optical nerve head blood flow velocity in order to preserve sight
PCT/US1996/007225 WO1996037203A1 (en) 1995-05-22 1996-05-17 Method to increase retinal blood flow

Publications (3)

Publication Number Publication Date
NO975330D0 NO975330D0 (no) 1997-11-20
NO975330L NO975330L (no) 1998-01-07
NO318600B1 true NO318600B1 (no) 2005-04-18

Family

ID=23770397

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975330A NO318600B1 (no) 1995-05-22 1997-11-20 Anvendelse av en karboanhydraseinhibitor for okning av blodstromshastigheten i retina og optisk nervehode for a bevare synet

Country Status (20)

Country Link
US (1) US5789435A (cs)
EP (1) EP0833632A1 (cs)
JP (1) JPH11503462A (cs)
KR (1) KR19990021853A (cs)
CN (1) CN1186019C (cs)
AU (1) AU703301B2 (cs)
BG (1) BG63148B1 (cs)
BR (1) BR9609297A (cs)
CA (1) CA2218549C (cs)
CZ (1) CZ289224B6 (cs)
EE (1) EE9700361A (cs)
HU (1) HUP9802553A3 (cs)
IS (1) IS4611A (cs)
NO (1) NO318600B1 (cs)
NZ (1) NZ308016A (cs)
RU (1) RU2181045C2 (cs)
SK (1) SK283960B6 (cs)
TR (1) TR199701406T1 (cs)
UA (1) UA48178C2 (cs)
WO (1) WO1996037203A1 (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999000133A1 (en) * 1997-06-26 1999-01-07 Merck & Co., Inc. Method for optimizing retinal and optic nerve health
US6126037A (en) * 1997-09-09 2000-10-03 Merck & Co., Inc. Flow control orifice
WO1999030717A1 (en) * 1997-12-12 1999-06-24 Alcon Laboratories, Inc. Use of brinzolamide for the manufacture of a medicament for improving ocular blood flow
DE69928771T2 (de) * 1998-01-23 2006-09-07 Einar Stefansson Carbonische anhydrase inhibitor zur steigerung des sauerstoffdrucks im sehnerv und retina
CA2323749A1 (en) * 1998-03-06 1999-09-10 William E. Sponsel Composition and method for treating macular disorders
WO2004073708A1 (en) 1998-12-17 2004-09-02 Dean Thomas R Brinzolamide and brimonidine for treating ocular conditions
JP4717996B2 (ja) * 2000-10-11 2011-07-06 サーパス工業株式会社 容器及びそれに用いるプラグ
US20040046934A1 (en) * 2002-02-14 2004-03-11 Board Of Regents, The University Of Texas System Oculokinetic offset acuity testing
RU2232582C2 (ru) * 2002-07-29 2004-07-20 Уфимский научно-исследовательский институт глазных болезней Глазная пленка
US20040242457A1 (en) * 2003-05-27 2004-12-02 Ashby Charles R. Use of anti-glaucoma drugs to treat visual defects associated with the use of a GABAergic agent
GB2413282B (en) * 2004-04-23 2009-01-14 Henderson Morley Plc DNA Viral Infections
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
MX2007011165A (es) * 2007-09-12 2009-03-11 Arturo Jimenez Bayardo Composición farmacéutica estable de timolol, dorzolamida y brimonidina.
US10363245B2 (en) 2017-02-22 2019-07-30 The Board Of Regents Of The University Of Texas System Methods for treating CNS lesions
WO2019108866A1 (en) 2017-12-03 2019-06-06 Natureworks Llc Polylactic resin compositions for paperboard coating and paperboard coating processes using the compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416890A (en) * 1981-07-13 1983-11-22 Merck & Co., Inc. Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
US4386098A (en) * 1981-11-03 1983-05-31 Merck & Co., Inc. 6-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure
US4426388A (en) * 1982-04-02 1984-01-17 Merck & Co., Inc. 5-Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
US4797413A (en) * 1986-05-14 1989-01-10 Merck & Co., Inc. Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
GB2203039B (en) * 1987-03-02 1990-10-24 American Cyanamid Co Stable ophthalmic preparations containing acetazolamide
US5494901A (en) * 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent

Also Published As

Publication number Publication date
BG63148B1 (bg) 2001-05-31
CN1186019C (zh) 2005-01-26
EP0833632A4 (cs) 1998-05-20
JPH11503462A (ja) 1999-03-26
AU5754096A (en) 1996-12-11
NO975330L (no) 1998-01-07
HUP9802553A2 (hu) 1999-04-28
BG102064A (en) 1998-07-31
HK1020166A1 (en) 2000-03-31
SK153597A3 (en) 1998-07-08
IS4611A (is) 1997-11-10
EE9700361A (et) 1998-06-15
NZ308016A (en) 2000-09-29
KR19990021853A (ko) 1999-03-25
EP0833632A1 (en) 1998-04-08
RU2181045C2 (ru) 2002-04-10
UA48178C2 (uk) 2002-08-15
WO1996037203A1 (en) 1996-11-28
SK283960B6 (sk) 2004-06-08
TR199701406T1 (xx) 1998-03-21
CN1199336A (zh) 1998-11-18
HUP9802553A3 (en) 2002-01-28
CA2218549A1 (en) 1996-11-28
CZ289224B6 (cs) 2001-12-12
US5789435A (en) 1998-08-04
CA2218549C (en) 2005-09-20
MX9709063A (es) 1998-10-31
CZ369497A3 (cs) 1998-06-17
BR9609297A (pt) 1999-08-17
NO975330D0 (no) 1997-11-20
AU703301B2 (en) 1999-03-25

Similar Documents

Publication Publication Date Title
NO318600B1 (no) Anvendelse av en karboanhydraseinhibitor for okning av blodstromshastigheten i retina og optisk nervehode for a bevare synet
JP2007217437A (ja) カリウムチャンネル遮断剤の投与により、哺乳動物の眼圧を降下する方法
JPWO2008096804A1 (ja) ラタノプロスト含有点眼剤
WO2021039748A1 (ja) ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物
JP7320915B2 (ja) 眼科組成物
JP4836401B2 (ja) 眼科用組成物
NO320043B1 (no) Anvendelse av karboniske anhydraseinhibitorer for fremstilling av et medikament for behandling eller forebyggelse av makulaer odem eller aldersrelatert makulaer degenerering
CN1295476A (zh) 眼用组合物
US5523301A (en) Optic nerve health
JP2002506461A (ja) 網膜及び視神経の健康の最適化方法
JPH08511024A (ja) 眼内圧を低下させる方法および組成物
JP2009096793A (ja) プラノプロフェン含有水性医薬組成物
WO1993023032A1 (en) Remedy for cataract and production thereof
CN1080850A (zh) 眼科用阿尔加托品烷制剂
LU87087A1 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines
AU2001292351B2 (en) Remedies for retinal nerve diseases containing 1,2-ethanediol derivatives or salts thereof
HK1020166B (en) Method to increase retinal blood flow
JP3530542B2 (ja) 眼科用アルガトロバン製剤
MXPA97009063A (en) Use of carbonic anhydrase to prepare a composition to increase the blood flow of the retina and composition of the

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees